|
Re: 8 Minutes at AHA
|
10
|
Resverlogix Corp.
|
Oct 25, 2019 02:52PM
|
|
Re: 8 Minutes at AHA
|
3
|
Resverlogix Corp.
|
Oct 25, 2019 04:37PM
|
|
Re: 8 Minutes at AHA
|
2
|
Resverlogix Corp.
|
Oct 25, 2019 05:52PM
|
|
Re: A Don Gone PR..,,
|
7
|
Resverlogix Corp.
|
Sep 15, 2020 05:16PM
|
|
Re: A fair and optimistic write up on BETonMACE
|
4
|
Resverlogix Corp.
|
Nov 23, 2019 02:02PM
|
|
Re: A fair and optimistic write up on BETonMACE
|
6
|
Resverlogix Corp.
|
Nov 25, 2019 09:01AM
|
|
Re: A few thoughts
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 01:26PM
|
|
Re: A few thoughts
|
1
|
Resverlogix Corp.
|
Nov 16, 2019 01:42PM
|
|
Re: A few thoughts
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 01:57PM
|
|
Re: A few thoughts
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 02:22PM
|
|
Re: A few thoughts
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 02:53PM
|
|
Re: A non-rose coloured view of the Webcast
|
3
|
Resverlogix Corp.
|
Nov 02, 2019 01:43PM
|
|
Re: A non-rose coloured view of the Webcast
|
2
|
Resverlogix Corp.
|
Nov 02, 2019 02:09PM
|
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
5
|
Resverlogix Corp.
|
Oct 26, 2020 03:59PM
|
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
4
|
Resverlogix Corp.
|
Oct 26, 2020 06:11PM
|
|
Re: A significant corporate advancement? The market doesn't seem to agree....
|
5
|
Resverlogix Corp.
|
Jan 17, 2020 12:37PM
|
|
Re: About that stroke failure
|
6
|
Resverlogix Corp.
|
Dec 13, 2019 07:46PM
|
|
Re: About that stroke failure
|
2
|
Resverlogix Corp.
|
Dec 13, 2019 07:50PM
|
|
Re: ACE2 and Covid
|
2
|
Resverlogix Corp.
|
Sep 25, 2020 04:39PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
11
|
Resverlogix Corp.
|
May 19, 2020 06:17PM
|
